Seeing Is Believing

Currently out of the existing stock ratings of Florent Cespedes, 1 are a HOLD (12.5%), 3 are a SELL (37.5%), 4 are a BUY (50%).
Analyst Florent Cespedes, currently employed at SOCGEN, carries an average stock price target met ratio of 50% that have a potential upside of 18.32% achieved within 345 days.
Florent Cespedes’s has documented 16 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LLY, Eli Lilly and Company at 16-Feb-2023.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 11/3/2020. The price target of $30.79 was fulfilled within 1 day with a profit of $0.83 (2.77%) receiving and performance score of 27.7.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 18-Nov-2022
$1250
$186.44 (17.53%)
$1080
5 days ago
(07-Jan-2026)
7/9 (77.78%)
$185.96 (17.48%)
138
Buy
Since 10-Dec-2020
$1268
$204.44 (19.22%)
$997
28 days ago
(15-Dec-2025)
5/7 (71.43%)
$240.49 (23.41%)
198
Buy
Since 22-Apr-2020
$1268
$204.44 (19.22%)
$500
28 days ago
(15-Dec-2025)
5/6 (83.33%)
$240.49 (23.41%)
200
Buy
Since 13-Mar-2023
$1200
$136.44 (12.83%)
$1100
1 months 2 days ago
(10-Dec-2025)
17/18 (94.44%)
$206.36 (20.77%)
130
Buy
Since 24-Jan-2022
$1290
$226.44 (21.29%)
$1171
1 months 19 days ago
(24-Nov-2025)
33/38 (86.84%)
$219.84 (20.54%)
201
What Year was the first public recommendation made by Florent Cespedes?